arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 0805.2845stat.AP
收藏

健康生活方式的统计调整并不能得出激素治疗的真相

Statistical adjustment for a measure of healthy lifestyle doesn't yield the truth about hormone therapy

Diana B. Petitti, Wansu Chen

摘要:

妇女健康倡议的激素治疗随机临床试验发现,激素在预防心血管疾病方面没有任何好处,这一发现与大量的观察性研究形成了鲜明的对比。了解更好的方法和/或统计调整是否可以防止观察性研究的错误结论是重要的。这是一项对绝经后激素治疗与心肌梗死(MI)和缺血性卒中风险关系的病例对照研究数据的再分析,我们报告这两种事件的风险总体上没有增加或减少。测量不太可能与MI和卒中风险存在因果关系的健康行为/生活方式的变量(例如,防晒霜使用)与传统混杂因素一起纳入多变量分析(年龄、高血压、糖尿病、吸烟、体重指数、种族、教育、MI的既往冠心病和卒中的既往卒中/TIA),以确定对健康行为/生活方式变量的调整是否可以重现或使结果更接近激素治疗的大型明确随机临床试验的结果,妇女健康倡议对于MI和卒中,健康行为/生活方式的测量与比值比(OR)小于1.0相关。传统心血管疾病混杂因素的调整并没有改变MI或卒中的OR值。将使用逐步回归选择的这些变量的子集与传统的心血管疾病混杂因素一起添加到最终的MI或卒中模型中,使雌激素和雌激素/阿托伐他汀使用的OR更接近妇女健康倡议临床试验中观察到的值,但不能可靠地重现这两个终点的临床试验结果。

英文摘要:

The Women's Health Initiative randomized clinical trial of hormone therapy found no benefit of hormones in preventive cardiovascular disease, a finding in striking contrast with a large body of observational research. Understanding whether better methodology and/or statistical adjustment might have prevented the erroneous conclusions of observational research is important. This is a re-analysis of data from a case-control study examining the relationship of postmenopausal hormone therapy and the risks of myocardial infarction (MI) and ischemic stroke in which we reported no overall increase or decrease in the risk of either event. Variables measuring health behavior/lifestyle that are not likely to be causally with the risks of MI and stroke (e.g., sunscreen use) were included in multivariate analysis along with traditional confounders (age, hypertension, diabetes, smoking, body mass index, ethnicity, education, prior coronary heart disease for MI and prior stroke/TIA for stroke) to determine whether adjustment for the health behavior/lifestyle variables could reproduce or bring the results closer to the findings in a large and definitive randomized clinical trial of hormone therapy, the Women's Health Initiative. For both MI and stroke, measures of health behavior/lifestyle were associated with odds ratios (ORs) less than 1.0. Adjustment for traditional cardiovascular disease confounders did not alter the magnitude of the ORs for MI or stroke. Addition of a subset of these variables selected using stepwise regression to the final MI or stroke models along with the traditional cardiovascular disease confounders moved the ORs for estrogen and estrogen/progestin use closer to values observed in the Women Health Initiative clinical trial, but did not reliably reproduce the clinical trial results for these two endpoints.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑